Anavex life sciences to present at the 22nd annual needham virtual healthcare conference 2023

New york, april 10, 2023 (globe newswire) -- anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including alzheimer's disease, parkinson's disease, rett syndrome and other central nervous system (cns) diseases, today announced that christopher u missling, phd, president & chief executive officer of anavex will present at the 22nd annual needham virtual healthcare conference 2023 on monday, april 17, 2023, at 8:00 am et.
AVXL Ratings Summary
AVXL Quant Ranking